| Systemic Sclerosis and Related Diseases | Lifetime | 47 | CN 1 | 99.44 |
| Selenium in Biological Systems | Lifetime | 29 | CN 4 | 99.29 |
| Trace Elements in Health | Lifetime | 98 | CN 4 | 99.05 |
| Connective Tissue Growth Factor Research | Lifetime | 11 | CN 2 | 98.92 |
| Heavy Metal Exposure and Toxicity | Lifetime | 102 | CN 10 | 99.08 |
| Dermatologic Treatments and Research | Lifetime | 128 | CN 1 | 98.41 |
| Environmental Toxicology and Ecotoxicology | Lifetime | 389 | CN 34 | 97.95 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 529 | CN 3 | 97.36 |
| Medical and Biological Ozone Research | Lifetime | 121 | CN 10 | 94.79 |
| Microplastics and Plastic Pollution | Lifetime | 922 | CN 274 | 95.36 |
| Fibroblast Growth Factor Research | Lifetime | 477 | CN 28 | 94.04 |
| Dermatological and Skeletal Disorders | Lifetime | 418 | CN 7 | 92.71 |
| Pesticide Exposure and Toxicity | Lifetime | 928 | CN 29 | 92.09 |
| Moringa oleifera research and applications | Lifetime | 723 | CN 48 | 89.66 |
| Paraquat toxicity studies and treatments | Lifetime | 421 | CN 71 | 67.73 |
| Trace Elements in Health | 2021-2025 | 5 | CN 2 | 99.04 |
| Heavy Metal Exposure and Toxicity | 2021-2025 | 14 | CN 5 | 99.14 |
| Selenium in Biological Systems | 2021-2025 | 13 | CN 5 | 97.94 |
| Inflammasome and immune disorders | 2021-2025 | 50 | CN 20 | 97.33 |
| Microplastics and Plastic Pollution | 2021-2025 | 230 | CN 94 | 97.40 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 115 | CN 4 | 95.82 |
| Nanoparticles: synthesis and applications | 2021-2025 | 318 | CN 42 | 95.28 |
| Environmental Toxicology and Ecotoxicology | 2021-2025 | 159 | CN 44 | 93.94 |
| Effects and risks of endocrine disrupting chemicals | 2021-2025 | 248 | CN 91 | 92.43 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 131 | CN 39 | 90.25 |
| Ferroptosis and cancer prognosis | 2021-2025 | 765 | CN 649 | 91.27 |
| Graphene and Nanomaterials Applications | 2021-2025 | 598 | CN 154 | 89.94 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 56 | CN 21 | 83.43 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 129 | CN 61 | 84.49 |
| Connective Tissue Growth Factor Research | 2021-2025 | 32 | CN 1 | 83.25 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 285 | CN 118 | 79.32 |
| NF-κB Signaling Pathways | 2021-2025 | 172 | CN 58 | 67.65 |
| Paraquat toxicity studies and treatments | 2021-2025 | 45 | CN 26 | 70.06 |
| Pesticide Exposure and Toxicity | 2021-2025 | 606 | CN 75 | 72.72 |
| Medical and Biological Ozone Research | 2021-2025 | 206 | CN 36 | 71.77 |
